Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Intervention Indication Therapeutic Area Year Actions
Daratumumab in addition to cyclophosphamide, bortezomib and dexamethasone for newly diagnosed systemic amyloid light-chain amyloidosis Bortezomib (Velcade; bortezomib mannitol boronic ester) , Cyclophosphamide (Procytox; cyclophosphamide monohydrate) , Daratumumab (Darzalex; JNJ-54767414) , Dexamethasone (dexamethasone sodium metasulfobenzoate) Amyloidosis Endocrine Nutritional and Metabolic Disorders 2020 View  |  Download
NEOD001 for amyloid light-chain (AL) amyloidosis Birtamimab (NEOD001) Amyloidosis Endocrine Nutritional and Metabolic Disorders 2017 View  |  Download
Vutrisiran for treating hereditary transthyretin amyloidosis Vutrisiran (ALN-TTRSC02) Amyloidosis Endocrine, nutritional and metabolic disorders 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications